Literature DB >> 31578291

How HIV Nef Proteins Hijack Membrane Traffic To Promote Infection.

Cosmo Z Buffalo1, Yuichiro Iwamoto1, James H Hurley1,2, Xuefeng Ren3.   

Abstract

The accessory protein Nef of human immunodeficiency virus (HIV) is a primary determinant of viral pathogenesis. Nef is abundantly expressed during infection and reroutes a variety of cell surface proteins to disrupt host immunity and promote the viral replication cycle. Nef counteracts host defenses by sequestering and/or degrading its targets via the endocytic and secretory pathways. Nef does this by physically engaging a number of host trafficking proteins. Substantial progress has been achieved in identifying the targets of Nef, and a structural and mechanistic understanding of Nef's ability to command the protein trafficking machinery has recently started to coalesce. Comparative analysis of HIV and simian immunodeficiency virus (SIV) Nef proteins in the context of recent structural advances sheds further light on both viral evolution and the mechanisms whereby trafficking is hijacked. This review describes how advances in cell and structural biology are uncovering in growing detail how Nef subverts the host immune system, facilitates virus release, and enhances viral infectivity.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  Nef; antiviral restriction factors; host-pathogen; human immunodeficiency virus; immune receptors; lentiviruses; protein structure; simian immunodeficiency virus; trafficking

Mesh:

Substances:

Year:  2019        PMID: 31578291      PMCID: PMC6880166          DOI: 10.1128/JVI.01322-19

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  187 in total

1.  Mechanism for down-regulation of CD28 by Nef.

Authors:  T Swigut; N Shohdy; J Skowronski
Journal:  EMBO J       Date:  2001-04-02       Impact factor: 11.598

2.  The structures of COPI-coated vesicles reveal alternate coatomer conformations and interactions.

Authors:  Marco Faini; Simone Prinz; Rainer Beck; Martin Schorb; James D Riches; Kirsten Bacia; Britta Brügger; Felix T Wieland; John A G Briggs
Journal:  Science       Date:  2012-05-24       Impact factor: 47.728

3.  Activated peripheral CD8 lymphocytes express CD4 in vivo and are targets for infection by human immunodeficiency virus type 1.

Authors:  S Imlach; S McBreen; T Shirafuji; C Leen; J E Bell; P Simmonds
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

4.  Optimal infectivity in vitro of human immunodeficiency virus type 1 requires an intact nef gene.

Authors:  M Y Chowers; C A Spina; T J Kwoh; N J Fitch; D D Richman; J C Guatelli
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

5.  Association of human immunodeficiency virus Nef protein with actin is myristoylation dependent and influences its subcellular localization.

Authors:  O T Fackler; N Kienzle; E Kremmer; A Boese; B Schramm; T Klimkait; C Kücherer; N Mueller-Lantzsch
Journal:  Eur J Biochem       Date:  1997-08-01

6.  Downregulation of CD4 by human immunodeficiency virus type 1 Nef is dependent on clathrin and involves direct interaction of Nef with the AP2 clathrin adaptor.

Authors:  Rittik Chaudhuri; O Wolf Lindwasser; William J Smith; James H Hurley; Juan S Bonifacino
Journal:  J Virol       Date:  2007-01-31       Impact factor: 5.103

7.  The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein.

Authors:  Nanette Van Damme; Daniel Goff; Chris Katsura; Rebecca L Jorgenson; Richard Mitchell; Marc C Johnson; Edward B Stephens; John Guatelli
Journal:  Cell Host Microbe       Date:  2008-03-13       Impact factor: 21.023

8.  Autophagy pathway intersects with HIV-1 biosynthesis and regulates viral yields in macrophages.

Authors:  George B Kyei; Christina Dinkins; Alexander S Davis; Esteban Roberts; Sudha B Singh; Chunsheng Dong; Li Wu; Eiki Kominami; Takashi Ueno; Akitsugu Yamamoto; Maurizio Federico; Antonito Panganiban; Isabelle Vergne; Vojo Deretic
Journal:  J Cell Biol       Date:  2009-07-27       Impact factor: 10.539

9.  The tyrosine binding pocket in the adaptor protein 1 (AP-1) mu1 subunit is necessary for Nef to recruit AP-1 to the major histocompatibility complex class I cytoplasmic tail.

Authors:  Elizabeth R Wonderlich; Maya Williams; Kathleen L Collins
Journal:  J Biol Chem       Date:  2007-12-11       Impact factor: 5.157

10.  Nef Secretion into Extracellular Vesicles or Exosomes Is Conserved across Human and Simian Immunodeficiency Viruses.

Authors:  Ryan P McNamara; Lindsey M Costantini; T Alix Myers; Blake Schouest; Nicholas J Maness; Jack D Griffith; Blossom A Damania; Andrew G MacLean; Dirk P Dittmer
Journal:  mBio       Date:  2018-02-06       Impact factor: 7.867

View more
  10 in total

Review 1.  Structure, function, and inhibitor targeting of HIV-1 Nef-effector kinase complexes.

Authors:  Ryan P Staudt; John J Alvarado; Lori A Emert-Sedlak; Haibin Shi; Sherry T Shu; Thomas E Wales; John R Engen; Thomas E Smithgall
Journal:  J Biol Chem       Date:  2020-08-29       Impact factor: 5.157

2.  Inhibitors of HIV-1 Nef-Mediated Activation of the Myeloid Src-Family Kinase Hck Block HIV-1 Replication in Macrophages and Disrupt MHC-I Downregulation.

Authors:  Lori A Emert-Sedlak; Omar Moukha-Chafiq; Haibin Shi; Shoucheng Du; John J Alvarado; Vibha Pathak; Samuel G Tanner; Robert N Hunter; Miranda Nebane; Li Chen; Tatiana V Ilina; Rieko Ishima; Sixue Zhang; Yury V Kuzmichev; Elizabeth R Wonderlich; Susan M Schader; Corinne E Augelli-Szafran; Roger G Ptak; Thomas E Smithgall
Journal:  ACS Infect Dis       Date:  2022-01-05       Impact factor: 5.578

3.  Concanamycin A counteracts HIV-1 Nef to enhance immune clearance of infected primary cells by cytotoxic T lymphocytes.

Authors:  Mark M Painter; Gretchen E Zimmerman; Madeline S Merlino; Andrew W Robertson; Valeri H Terry; Xuefeng Ren; Megan R McLeod; Lyanne Gomez-Rodriguez; Kirsten A Garcia; Jolie A Leonard; Kay E Leopold; Andrew J Neevel; Jay Lubow; Eli Olson; Alicja Piechocka-Trocha; David R Collins; Ashootosh Tripathi; Malini Raghavan; Bruce D Walker; James H Hurley; David H Sherman; Kathleen L Collins
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-08       Impact factor: 11.205

Review 4.  Biomechanics of T Cell Dysfunctions in Chronic Diseases.

Authors:  Sachith D Gunasinghe; Newton G Peres; Jesse Goyette; Katharina Gaus
Journal:  Front Immunol       Date:  2021-02-25       Impact factor: 7.561

Review 5.  HIV Neuroinflammation: The Role of Exosomes in Cell Signaling, Prognostic and Diagnostic Biomarkers and Drug Delivery.

Authors:  Supriya D Mahajan; Nigel Smith Ordain; Hilliard Kutscher; Shanta Karki; Jessica L Reynolds
Journal:  Front Cell Dev Biol       Date:  2021-04-01

6.  Characterization of SARS-CoV-2 proteins reveals Orf6 pathogenicity, subcellular localization, host interactions and attenuation by Selinexor.

Authors:  Jin-Gu Lee; Weiliang Huang; Hangnoh Lee; Joyce van de Leemput; Maureen A Kane; Zhe Han
Journal:  Cell Biosci       Date:  2021-03-25       Impact factor: 7.133

Review 7.  Drug Repurposing Approaches to Combating Viral Infections.

Authors:  Jay Trivedi; Mahesh Mohan; Siddappa N Byrareddy
Journal:  J Clin Med       Date:  2020-11-23       Impact factor: 4.241

Review 8.  Viral Interactions with Adaptor-Protein Complexes: A Ubiquitous Trait among Viral Species.

Authors:  Ivana Strazic Geljic; Paola Kucan Brlic; Lucija Musak; Dubravka Karner; Andreja Ambriović-Ristov; Stipan Jonjic; Peter Schu; Tihana Lenac Rovis
Journal:  Int J Mol Sci       Date:  2021-05-17       Impact factor: 5.923

Review 9.  HIV-1 Hijacking of Host ATPases and GTPases That Control Protein Trafficking.

Authors:  Lucas A Tavares; Yunan C Januário; Luis L P daSilva
Journal:  Front Cell Dev Biol       Date:  2021-07-08

Review 10.  Addressing an HIV cure in LMIC.

Authors:  Sherazaan D Ismail; Joshua Pankrac; Emmanuel Ndashimye; Jessica L Prodger; Melissa-Rose Abrahams; Jamie F S Mann; Andrew D Redd; Eric J Arts
Journal:  Retrovirology       Date:  2021-08-03       Impact factor: 4.602

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.